GHSR功能缺失变异与身材矮小及低IGF-I相关
该病例系列纳入26例携带GHSR杂合变异的身材矮小患者,体外实验显示变异导致受体部分或完全功能缺失,主要表现为组成型活性丧失。患者表现为匀称性矮小(身高-2.8±0.5 SDS)、血清IGF-I均值-1.6±0.7 SDS、刺激后GH反应正常;9例接受GH治疗者1年后身高增加0.9±0.4 SDS,2年后增加1.5±0.4 SDS(n=5)。
要点
- 携带GHSR杂合功能缺失变异的矮小儿童表现为匀称性矮小和低IGF-I,但刺激后GH反应正常。
- 体外实验显示变异主要通过组成型活性丧失导致受体部分或完全功能缺失。
- 9例接受GH治疗者1年后身高增加0.9±0.4 SDS,2年后增加1.5±0.4 SDS(n=5)。
核心结论
- 本研究在规模较大的携带GHSR变异的矮小儿童中结合表型与功能数据,显示其对GH治疗反应良好,结果支持GHSR在GH分泌中作用的假说。
研究设计与样本
- 病例系列研究,纳入26例身材矮小且携带GHSR杂合变异的患者,并在体外通过总蛋白水平、细胞表面表达及受体基础、刺激和抑制状态下的活性研究致病性。
主要发现
- 共鉴定10种不同变异,其中6种为新变异;变异显示部分或完全功能缺失,主要通过组成型活性丧失。
- 患者年龄4.0-15.1岁,表现为匀称性矮小(身高-2.8±0.5 SDS),4例有食欲低下和生长迟缓,血清IGF-I均值为-1.6±0.7 SDS,刺激后GH反应正常。
- 9例患者接受GH治疗,1年后身高增加0.9±0.4 SDS,2年后增加1.5±0.4 SDS(n=5)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The growth hormone (GH) secretagogue receptor, encoded by GHSR, is expressed on somatotrophs of the pituitary gland. Stimulation with its ligand ghrelin, as well as its constitutive activity, enhances GH secretion. Studies in knockout mice suggest that heterozygous loss-of-function of GHSR is associated with decreased GH response to fasting, but patient observations in small case reports have been equivocal. OBJECTIVE: This work aims to establish the phenotype of GHSR haploinsufficiency and its growth response to GH treatment. METHODS: This case series includes 26 patients with short stature and heterozygous GHSR variants. Pathogenicity was studied in vitro using total protein levels, cell surface expression, and receptor activity in basal, stimulated, and inhibited states. RESULTS: Ten different variants were identified, of which 6 were novel. Variants showed either partial or complete loss of function, primarily through loss of constitutive activity. Patients (aged 4.0-15.1 years) had proportionate short stature (height -2.8 ± 0.5 SDS), failure to thrive with low appetite (n = 4), a mean serum insulin-like growth factor-I (IGF-I) of -1.6 ± 0.7 SDS, and a normal stimulated GH response. Nine patients received GH treatment, showing a height gain of 0.9 ± 0.4 SDS after 1 year and 1.5 ± 0.4 SDS after 2 years (n = 5). CONCLUSION: This study combines phenotypical and functional data in a uniquely large group of children with short stature carrying GHSR variants, and shows their good response to GH treatment. The results strengthen the hypothesis of GHSR's role in GH secretion.
引用
- Punt LD, Kooijman S, Mutsters NJM, et al. Loss-of-Function GHSR Variants Are Associated With Short Stature and Low IGF-I. J Clin Endocrinol Metab. 2025. PMID: 39785833. doi:10.1210/clinem/dgaf010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。